AUPH — Aurinia Pharmaceuticals Inc. stock price, charts and financials

QT76Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.90
-0.06-0.35%
OverviewShort InterestFilings
AUPHQT76Aurinia Pharmaceuticals Inc.·NASDAQ
16.90-0.35%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 11, 20264Statement of changes in beneficial ownership
Aug 26, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 25, 20264Statement of changes in beneficial ownership
Aug 19, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 04, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 02, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 11, 20268-KCurrent report
May 11, 2026SC TO-T/ASC TO-T/A
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 21, 2026DEF 14ADefinitive proxy statement
Apr 13, 2026SC TO-TThird-party tender offer statement
Apr 03, 20268-KCurrent report
Apr 02, 20263Initial statement of beneficial ownership
Apr 02, 20263Initial statement of beneficial ownership
#1 / 25 of 267
Page
▼
/ 11